Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventilator-Induced Lung Injury | 13 | 2024 | 20 | 4.280 |
Why?
|
| Respiration, Artificial | 15 | 2024 | 290 | 2.980 |
Why?
|
| Continuous Positive Airway Pressure | 8 | 2024 | 63 | 2.510 |
Why?
|
| Lung | 13 | 2024 | 507 | 1.890 |
Why?
|
| Pulmonary Alveoli | 7 | 2024 | 27 | 1.750 |
Why?
|
| Lung Injury | 4 | 2024 | 29 | 1.730 |
Why?
|
| Respiratory Mechanics | 4 | 2024 | 41 | 1.590 |
Why?
|
| Acute Lung Injury | 5 | 2023 | 25 | 1.220 |
Why?
|
| Lung Volume Measurements | 1 | 2024 | 8 | 0.960 |
Why?
|
| Insufflation | 1 | 2024 | 10 | 0.960 |
Why?
|
| Positive-Pressure Respiration | 2 | 2016 | 59 | 0.950 |
Why?
|
| Respiration | 1 | 2019 | 100 | 0.630 |
Why?
|
| Tidal Volume | 7 | 2024 | 60 | 0.600 |
Why?
|
| Swine | 7 | 2024 | 408 | 0.570 |
Why?
|
| Animals | 18 | 2024 | 13141 | 0.550 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2016 | 52 | 0.530 |
Why?
|
| Random Allocation | 5 | 2018 | 288 | 0.510 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1419 | 0.430 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 1581 | 0.300 |
Why?
|
| Exhalation | 2 | 2024 | 19 | 0.300 |
Why?
|
| Tetracyclines | 2 | 2023 | 9 | 0.260 |
Why?
|
| Vanillic Acid | 1 | 2024 | 2 | 0.240 |
Why?
|
| Oscillometry | 1 | 2024 | 9 | 0.240 |
Why?
|
| Hemostatics | 1 | 2024 | 17 | 0.240 |
Why?
|
| Abdomen | 1 | 2024 | 77 | 0.230 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2022 | 12 | 0.210 |
Why?
|
| Ventilators, Mechanical | 1 | 2022 | 44 | 0.190 |
Why?
|
| Pneumonia | 1 | 2022 | 118 | 0.180 |
Why?
|
| Humans | 15 | 2024 | 50201 | 0.180 |
Why?
|
| Sepsis | 1 | 2023 | 226 | 0.170 |
Why?
|
| Rats | 3 | 2015 | 3277 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 291 | 0.160 |
Why?
|
| Animals, Newborn | 2 | 2018 | 367 | 0.160 |
Why?
|
| Soaps | 1 | 2018 | 1 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2018 | 36 | 0.150 |
Why?
|
| Fiber Optic Technology | 1 | 2017 | 17 | 0.150 |
Why?
|
| Scattering, Radiation | 1 | 2017 | 31 | 0.140 |
Why?
|
| Pulmonary Ventilation | 1 | 2017 | 12 | 0.140 |
Why?
|
| Escherichia coli | 1 | 2018 | 191 | 0.140 |
Why?
|
| Light | 1 | 2017 | 70 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 230 | 0.140 |
Why?
|
| Infant Formula | 1 | 2018 | 145 | 0.140 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2016 | 3 | 0.130 |
Why?
|
| Thoracotomy | 1 | 2016 | 35 | 0.130 |
Why?
|
| Microscopy | 1 | 2016 | 59 | 0.130 |
Why?
|
| Epithelial Sodium Channels | 1 | 2015 | 9 | 0.120 |
Why?
|
| Models, Animal | 1 | 2016 | 228 | 0.120 |
Why?
|
| Electroporation | 1 | 2015 | 18 | 0.120 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2014 | 9 | 0.120 |
Why?
|
| Gene Transfer Techniques | 1 | 2015 | 38 | 0.120 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2014 | 22 | 0.120 |
Why?
|
| Heart | 1 | 2017 | 336 | 0.120 |
Why?
|
| Plasmids | 1 | 2015 | 164 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2014 | 174 | 0.110 |
Why?
|
| Caspase 1 | 2 | 2023 | 23 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2018 | 2770 | 0.100 |
Why?
|
| Time Factors | 1 | 2019 | 2909 | 0.100 |
Why?
|
| Pulmonary Atelectasis | 2 | 2024 | 12 | 0.100 |
Why?
|
| Inflammasomes | 2 | 2023 | 62 | 0.100 |
Why?
|
| Models, Biological | 1 | 2015 | 722 | 0.100 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 196 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2023 | 266 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2019 | 5203 | 0.090 |
Why?
|
| Risk Factors | 1 | 2019 | 3644 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2023 | 281 | 0.080 |
Why?
|
| Inflammation | 2 | 2023 | 608 | 0.080 |
Why?
|
| Mice | 3 | 2023 | 5673 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 1782 | 0.070 |
Why?
|
| Male | 3 | 2015 | 25572 | 0.070 |
Why?
|
| Apoptosis | 2 | 2023 | 1093 | 0.060 |
Why?
|
| Polymers | 1 | 2024 | 42 | 0.060 |
Why?
|
| Physics | 1 | 2024 | 1 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2024 | 58 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2024 | 73 | 0.060 |
Why?
|
| Lung Compliance | 1 | 2023 | 9 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2023 | 28 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 53 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2023 | 93 | 0.050 |
Why?
|
| Biofilms | 1 | 2024 | 181 | 0.050 |
Why?
|
| Creatinine | 1 | 2023 | 142 | 0.050 |
Why?
|
| Leukocyte Elastase | 1 | 2022 | 5 | 0.050 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2022 | 4 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2022 | 27 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 127 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2023 | 210 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 327 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 162 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2022 | 302 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 388 | 0.040 |
Why?
|
| Female | 2 | 2018 | 26829 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 744 | 0.040 |
Why?
|
| Fermentation | 1 | 2018 | 9 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2018 | 31 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2018 | 37 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2018 | 3 | 0.040 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Cellular Microenvironment | 1 | 2018 | 27 | 0.040 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Mast Cells | 1 | 2018 | 54 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 51 | 0.040 |
Why?
|
| Optical Fibers | 1 | 2017 | 8 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2018 | 111 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 86 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 122 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 1010 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 607 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2015 | 12 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2015 | 30 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2015 | 31 | 0.030 |
Why?
|
| Myocardium | 1 | 2017 | 443 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2015 | 188 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 871 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1195 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 1612 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1963 | 0.020 |
Why?
|